Colon cancer screening program in the Netherlands reduces death rate by 45 percent
The Dutch National Institute for Public Health (RIVM) reports remarkable results from its colon cancer screening program, with analysis from Erasmus MC showing a significant drop in mortality since 2014.

The national colorectal cancer screening program in the Netherlands has led to a dramatic 45 percent reduction in deaths among those who participated since its launch in 2014, according to a new analysis by Erasmus MC. The Dutch National Institute for Public Health (RIVM) recently shared these results, highlighting the positive impact the long-term screening initiative has had on public health policy. The study reflects nine years of tracking participants and assessing health outcomes.
Detailed analyses of these long-term cases were made publicly available, emphasizing how early detection not only extends patients’ lifespans but also brings significant savings to the healthcare system. Erasmus MC’s findings underline the crucial role that widespread screening programs play in the fight against colon cancer.
Dutch health officials, including RIVM and the Ministry of Health, aim to further expand the reach of the program by continuing regular screenings across various age groups nationwide. Researchers note that the success in the Netherlands could serve as a model for similar programs in other countries seeking to lower colon cancer mortality rates.





